Marcel Borger

Marcel Borger

26 Jun, 2025

“We had a very good experience working alongside the Celegence medical device services team when drafting our clinical evaluation processes, and truly appreciate their highly professional and cooperative global regulatory experts. They took great care in understanding our CER/CEP and PSUR submission requirements.”

Other Related Articles

What is a Service+Tech Model? – The Fastest Path to Integrating AI into Regulatory Operations

Blog Medical Devices

What is a Service+Tech Model? – The Fastest Path to Integrating AI into Regulatory Operations

11 Nov, 2025

From Spreadsheets to Strategic Assets: Key Takeaways from Our Regulatory Data Management Webinar

Blog Pharmaceutical

From Spreadsheets to Strategic Assets: Key Takeaways from Our Regulatory Data Management Webinar

04 Nov, 2025

Sonia Veluchamy Named Among Crain’s Top Health Tech Leaders 2025

Company News

Sonia Veluchamy Named Among Crain’s Top Health Tech Leaders 2025

28 Oct, 2025

Regulatory Approvals in Africa: Key Frameworks, Challenges, and Emerging Trends

Blog Pharmaceutical

Regulatory Approvals in Africa: Key Frameworks, Challenges, and Emerging Trends

21 Oct, 2025

AI and Data Privacy & Compliance: How is Your Data Protected?

Blog Medical Devices

AI and Data Privacy & Compliance: How is Your Data Protected?

14 Oct, 2025

EU Fluorinated Greenhouse Gases Regulation: Guidance for Pharma Manufacturers

Blog Pharmaceutical

EU Fluorinated Greenhouse Gases Regulation: Guidance for Pharma Manufacturers

08 Oct, 2025

Beyond Automation: How AI Transforms Clinical Evaluation Reports into Strategic Regulatory Assets

Blog Medical Devices

Beyond Automation: How AI Transforms Clinical Evaluation Reports into Strategic Regulatory Assets

03 Oct, 2025

EU Regulatory Challenges and Considerations in Radiopharmaceuticals

Blog Pharmaceutical

EU Regulatory Challenges and Considerations in Radiopharmaceuticals

24 Sep, 2025

View All